vs
Workday, Inc.（WDAY）与硕腾（ZTS）财务数据对比。点击上方公司名可切换其他公司
Workday, Inc.的季度营收约是硕腾的1.0倍（$2.4B vs $2.4B），硕腾净利率更高（25.3% vs 10.4%，领先14.9%），Workday, Inc.同比增速更快（12.6% vs 3.0%），硕腾自由现金流更多（$732.0M vs $550.0M），过去两年Workday, Inc.的营收复合增速更高（12.5% vs 4.4%）
Workday是全球领先的企业级云软件供应商，核心产品覆盖人力资本管理、财务管理及企业资源规划解决方案，主要服务教育、医疗、金融、科技等行业的中大型机构，业务遍布北美、欧洲、亚太等全球主要市场。
硕腾是全球规模最大的动物保健制药企业，专注于宠物与家畜用药品、疫苗的研发和生产，前身为制药巨头辉瑞旗下的动物保健业务板块，辉瑞剥离多数股权后成为完全独立的企业。目前公司产品直销约45个国家，在全球超过100个国家和地区销售，海外业务占总营收的50%左右。
WDAY vs ZTS — 直观对比
营收规模更大
WDAY
是对方的1.0倍
$2.4B
营收增速更快
WDAY
高出9.6%
3.0%
净利率更高
ZTS
高出14.9%
10.4%
自由现金流更多
ZTS
多$182.0M
$550.0M
两年增速更快
WDAY
近两年复合增速
4.4%
损益表 — Q3 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $2.4B | $2.4B |
| 净利润 | $252.0M | $603.0M |
| 毛利率 | — | 70.2% |
| 营业利润率 | 10.6% | 31.9% |
| 净利率 | 10.4% | 25.3% |
| 营收同比 | 12.6% | 3.0% |
| 净利润同比 | 30.6% | 3.8% |
| 每股收益（稀释后） | $0.94 | $1.37 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收WDAYZTS
| Q4 25 | $2.4B | $2.4B | ||
| Q3 25 | $2.3B | $2.4B | ||
| Q2 25 | $2.2B | $2.5B | ||
| Q1 25 | $2.2B | $2.2B | ||
| Q4 24 | $2.2B | $2.3B | ||
| Q3 24 | $2.1B | $2.4B | ||
| Q2 24 | $2.0B | $2.4B | ||
| Q1 24 | $1.9B | $2.2B |
净利润WDAYZTS
| Q4 25 | $252.0M | $603.0M | ||
| Q3 25 | $228.0M | $721.0M | ||
| Q2 25 | $68.0M | $718.0M | ||
| Q1 25 | $94.0M | $631.0M | ||
| Q4 24 | $193.0M | $581.0M | ||
| Q3 24 | $132.0M | $682.0M | ||
| Q2 24 | $107.0M | $624.0M | ||
| Q1 24 | $1.2B | $599.0M |
毛利率WDAYZTS
| Q4 25 | — | 70.2% | ||
| Q3 25 | — | 71.5% | ||
| Q2 25 | — | 73.6% | ||
| Q1 25 | — | 72.0% | ||
| Q4 24 | — | 69.5% | ||
| Q3 24 | — | 70.6% | ||
| Q2 24 | — | 71.7% | ||
| Q1 24 | — | 70.6% |
营业利润率WDAYZTS
| Q4 25 | 10.6% | 31.9% | ||
| Q3 25 | 10.6% | 37.0% | ||
| Q2 25 | 1.7% | 36.7% | ||
| Q1 25 | 3.4% | 36.5% | ||
| Q4 24 | 7.6% | 31.6% | ||
| Q3 24 | 5.3% | 36.6% | ||
| Q2 24 | 3.2% | 33.0% | ||
| Q1 24 | 4.1% | 34.1% |
净利率WDAYZTS
| Q4 25 | 10.4% | 25.3% | ||
| Q3 25 | 9.7% | 30.0% | ||
| Q2 25 | 3.0% | 29.2% | ||
| Q1 25 | 4.3% | 28.4% | ||
| Q4 24 | 8.9% | 25.1% | ||
| Q3 24 | 6.3% | 28.6% | ||
| Q2 24 | 5.4% | 26.4% | ||
| Q1 24 | 61.8% | 27.4% |
每股收益（稀释后）WDAYZTS
| Q4 25 | $0.94 | $1.37 | ||
| Q3 25 | $0.84 | $1.63 | ||
| Q2 25 | $0.25 | $1.61 | ||
| Q1 25 | $0.34 | $1.41 | ||
| Q4 24 | $0.72 | $1.29 | ||
| Q3 24 | $0.49 | $1.50 | ||
| Q2 24 | $0.40 | $1.37 | ||
| Q1 24 | $4.48 | $1.31 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $6.8B | — |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $8.9B | $3.3B |
| 总资产 | $17.8B | $15.5B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资WDAYZTS
| Q4 25 | $6.8B | — | ||
| Q3 25 | $8.2B | $2.1B | ||
| Q2 25 | $8.0B | $1.4B | ||
| Q1 25 | $8.0B | $1.7B | ||
| Q4 24 | $7.2B | $2.0B | ||
| Q3 24 | $7.4B | $1.7B | ||
| Q2 24 | $7.2B | $1.6B | ||
| Q1 24 | $7.8B | $2.0B |
总债务WDAYZTS
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | $3.0B | — | ||
| Q1 24 | $3.0B | — |
股东权益WDAYZTS
| Q4 25 | $8.9B | $3.3B | ||
| Q3 25 | $9.2B | $5.4B | ||
| Q2 25 | $8.9B | $5.0B | ||
| Q1 25 | $9.0B | $4.7B | ||
| Q4 24 | $8.6B | $4.8B | ||
| Q3 24 | $8.3B | $5.2B | ||
| Q2 24 | $8.2B | $5.0B | ||
| Q1 24 | $8.1B | $5.1B |
总资产WDAYZTS
| Q4 25 | $17.8B | $15.5B | ||
| Q3 25 | $18.0B | $15.2B | ||
| Q2 25 | $17.2B | $14.5B | ||
| Q1 25 | $18.0B | $14.1B | ||
| Q4 24 | $16.4B | $14.2B | ||
| Q3 24 | $16.2B | $14.4B | ||
| Q2 24 | $15.9B | $14.2B | ||
| Q1 24 | $16.5B | $14.3B |
负债/权益比WDAYZTS
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 0.37× | — | ||
| Q1 24 | 0.37× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $588.0M | $893.0M |
| 自由现金流经营现金流 - 资本支出 | $550.0M | $732.0M |
| 自由现金流率自由现金流/营收 | 22.6% | 30.7% |
| 资本支出强度资本支出/营收 | 1.6% | 6.7% |
| 现金转化率经营现金流/净利润 | 2.33× | 1.48× |
| 过去12个月自由现金流最近4个季度 | $2.6B | $2.3B |
8季度趋势，按日历期对齐
经营现金流WDAYZTS
| Q4 25 | $588.0M | $893.0M | ||
| Q3 25 | $616.0M | $938.0M | ||
| Q2 25 | $457.0M | $486.0M | ||
| Q1 25 | $1.1B | $587.0M | ||
| Q4 24 | $406.0M | $905.0M | ||
| Q3 24 | $571.0M | $951.0M | ||
| Q2 24 | $372.0M | $502.0M | ||
| Q1 24 | $995.6M | $595.0M |
自由现金流WDAYZTS
| Q4 25 | $550.0M | $732.0M | ||
| Q3 25 | $588.0M | $805.0M | ||
| Q2 25 | $421.0M | $308.0M | ||
| Q1 25 | $1.0B | $438.0M | ||
| Q4 24 | $359.0M | $689.0M | ||
| Q3 24 | $516.0M | $784.0M | ||
| Q2 24 | $291.0M | $370.0M | ||
| Q1 24 | $947.6M | $455.0M |
自由现金流率WDAYZTS
| Q4 25 | 22.6% | 30.7% | ||
| Q3 25 | 25.0% | 33.5% | ||
| Q2 25 | 18.8% | 12.5% | ||
| Q1 25 | 46.4% | 19.7% | ||
| Q4 24 | 16.6% | 29.7% | ||
| Q3 24 | 24.7% | 32.8% | ||
| Q2 24 | 14.6% | 15.7% | ||
| Q1 24 | 49.3% | 20.8% |
资本支出强度WDAYZTS
| Q4 25 | 1.6% | 6.7% | ||
| Q3 25 | 1.2% | 5.5% | ||
| Q2 25 | 1.6% | 7.2% | ||
| Q1 25 | 3.9% | 6.7% | ||
| Q4 24 | 2.2% | 9.3% | ||
| Q3 24 | 2.6% | 7.0% | ||
| Q2 24 | 4.1% | 5.6% | ||
| Q1 24 | 2.5% | 6.4% |
现金转化率WDAYZTS
| Q4 25 | 2.33× | 1.48× | ||
| Q3 25 | 2.70× | 1.30× | ||
| Q2 25 | 6.72× | 0.68× | ||
| Q1 25 | 11.83× | 0.93× | ||
| Q4 24 | 2.10× | 1.56× | ||
| Q3 24 | 4.33× | 1.39× | ||
| Q2 24 | 3.48× | 0.80× | ||
| Q1 24 | 0.84× | 0.99× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
WDAY
| Subscription Services | $2.2B | 92% |
| Professional Services | $188.0M | 8% |
ZTS
| Other | $1.3B | 56% |
| Livestock | $234.0M | 10% |
| Pain Sedation | $209.0M | 9% |
| Other Pharmaceuticals | $188.0M | 8% |
| Swine | $125.0M | 5% |
| Poultry | $117.0M | 5% |
| Fish | $81.0M | 3% |
| Other Non Pharmaceuticals | $70.0M | 3% |
| Manufactured Product Other | $18.0M | 1% |
| Medicated Feed Additives | $12.0M | 1% |
